Join the Paxil group to help and get support from people like you.
Paxil News
Prenatal SSRI Exposure Linked to Functional Constipation in Offspring
FRIDAY, Dec. 13, 2024 – Prenatal exposure to selective serotonin reuptake inhibitors (SSRIs) is associated with an increased risk of functional constipation developing in offspring, according to a...
FDA Medwatch Alert: Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants: Drug Safety Communication - Use During Pregnancy and Potential Risk of Persistent Pulmonary Hypertension of the Newborn
Including Celexa (citalopram); Lexapro (escitalopram); Prozac, Sarafem, Symbyax (fluoxetine); Luvox, Luvox CR (fluvoxamine); Paxil, Paxil CR, Pexeva (paroxetine); Zoloft (sertraline); Viibryd...
FDA Medwatch Alert: Paxil (paroxetine)
[UPDATE 07/08/2005] FDA notified healthcare professionals about the availability of updated Healthcare Professional and Patient Information Sheets for antidepressant medications that were the subject...
FDA Medwatch Alert: Paxil (paroxetine HCL) and Paxil CR
[Posted 09/27/2005] GlaxoSmithKline (GSK) and FDA notified healthcare professionals of changes to the Pregnancy/PRECAUTIONS section of the Prescribing Information for Paxil and Paxil CR...
FDA Medwatch Alert: Paxil (paroxetine hydrochloride) - Jun 22, 2004
FDA and GlaxoSmithKline notified healthcare professionals of revisions to the WARNINGS and PRECAUTIONS sections of labeling to alert healthcare professionals that patients with major depressive...
FDA Medwatch Alert: Antidepressant Medication Products
[Posted 05/02/2007] FDA notified healthcare professionals that the Agency proposed that makers of all antidepressant medications update the existing black box warning on the prescribing information...
FDA Medwatch Alert: Selective Serotonin Reuptake Inhibitors (SSRIs) - Serotonin Syndrome
[Posted 07/19/2006] FDA notified healthcare professionals and consumers of new safety information regarding taking medications used to treat migraine headaches (triptans) together with certain types...
FDA Medwatch Alert: SSRIs and Treatment Challenges of Depression in Pregnancy
[Posted 07/19/2006] FDA notified healthcare professionals and consumers of important information from two recent studies that should be considered when making treatment decisions in pregnant women...
FDA Medwatch Alert: Paxil (paroxetine hydrochloride) - May 12, 2006
[Posted 05/12/2006] GlaxoSmithKline (GSK) and FDA notified healthcare professionals of changes to the Clinical Worsening and Suicide Risk subsection of the WARNINGS section in the prescribing...
FDA Medwatch Alert: Paroxetine HCl - Paxil and generic paroxetine
[Posted 12/08/2005] The FDA has determined that exposure to paroxetine in the first trimester of pregnancy may increase the risk for congenital malformations, particularly cardiac malformations. At...
FDA Medwatch Alert: Public Health Advisory: Antidepressant Use in Children, Adolescents, and Adults
The FDA asked manufacturers of the following antidepressant drugs to include in their labeling a Warning statement that recommends close observation of adult and pediatric patients for worsening...
FDA Medwatch Alert: Public Health Advisory - Suicidality in Pediatric Patients Treated with Antidepressants for Major Depressive Disorder
The FDA notified healthcare professionals of reports of the occurrence of suicidality (both suicidal ideation and suicide attempts) in clinical trials for various antidepressant drugs in pediatric...
Further information
Related condition support groups
Anxiety and Stress, Dysautonomia, Anxiety, Generalized Anxiety Disorder, Depression, Major Depressive Disorder, Obsessive Compulsive Disorder, Panic Disorder, Post Traumatic Stress Disorder, Postmenopausal Symptoms, Postpartum Depression, Social Anxiety Disorder